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Abstract 
 
Recently, we reported that acetylcholine-induced HIF-1D protects cardiomyocytes from 
hypoxia; however, the downstream factors reducing hypoxic stress are unknown. We 
identified apoptosis inhibitor (AI) gene as being differentially expressed between von 
Hippel Lindau (VHL) protein-positive cells with high levels of GRP78 expression and 
VHL-negative cells with lower GRP levels, using cDNA subtraction. AI decreased 
GRP78 level, suppressed mitochondrial function, reduced oxygen consumption and, 
ultimately, suppressed hypoxia-induced apoptosis. By contrast, knockdown of the AI 
gene increased mitochondrial function. Hypoxic cardiomyocytes and ischemic 
myocardium showed increased AI mRNA expression. These findings suggest that AI is 
involved in suppressing mitochondrial function, thereby leading to cellular stress 
eradication and consequently to protection during hypoxia.  
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Introduction 
 
To develop a novel therapeutic modality against heart failure, we extensively studied the 
cardioprotective effects of vagal nerve stimulation and the mechanisms underlying the 
anti-apoptotic actions of acetylcholine (ACh) [1]. Our previous study showed that 
induction of hypoxia-inducible factor (HIF)-1D is further activated by ACh in 
cardiomyocytes, even in normoxia. This additive induction of HIF-1D rescues 
cardiomyocytes from prolonged hypoxic stress and suppresses hypoxia-induced cell 
death [2]. These significant results prompted us to investigate which target genes are 
regulated by HIF-1D, and to reveal the mechanisms responsible for cardioprotection. 
 In order to escape from stresses, cells, including cardiomyocytes, possess self-defense 
systems, including HIF-1D induction against hypoxia, the unfolded protein response 
(UPR) against accumulated abnormal proteins, and the expression of heat shock 
proteins (Hsps) against heat shock [3-5]. Specifically, the stress induced by unfolded 
proteins in the endoplasmic reticulum (ER), ER stress, has been focused on as one of 
the causes of cardiovascular diseases, including cardiac hypertrophy and cardiac 
remodeling [6-8]. The ER plays crucial roles in protein folding and protein quality 
sensing, and is essential for cellular homeostasis. Therefore, ER stress is observed in 
situations where protein synthesis is augmented or cell proliferation is potentiated 
[9-11].  
Among a variety of stresses, we have focused on a cardiac defense mechanism 
mediated by HIF-1D. The HIF-1D protein level is regulated by a proteasome system 
involving von Hippel Lindau (VHL) protein [12-15]. HIF-1D transcriptionally regulates 
target genes involved in glycolysis, angiogenesis and adaptation against hypoxic stress; 
therefore, HIF-1D induction might provide cells with fewer stresses, leading to escape 
from hypoxic stress. However, it remains unclear which factors are involved in the 
anti-stress effects induced by HIF-1D.  
Recent studies have demonstrated that HIF-1D is induced through a nonhypoxic 
pathway mediated by cytokines, nitric oxide (NO) and ACh [2, 16]. These findings 
suggest that a cell defense system involving HIF-1D is modulated by molecules other 
than those involve in hypoxia. In order to elucidate the precise molecular mechanisms 
underlying the HIF-1D-regulated anti-stress effects, we compared VHL-negative and 
VHL-positive cells, that is, cells with higher and lower HIF-1D expression levels, 
respectively. We found that VHL-negative cells exhibited lower levels of ER stress. 
Using these cells, we subsequently performed a cDNA subtraction assay and identified a 
gene, apoptosis inhibitor (AI) gene, which may be involved in the anti-stress effects of 
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HIF-1D. 
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Materials and methods 
 
Cell Culture 
RCC4 cells, referred to as VHL-negative cells, and RCC4 cells with normal VHL 
expression, as VHL-positive cells, were generous gifts from Dr. Patrick H. Maxwell 
(The Wellcome Trust Center for Human Genetics, Oxford, UK) [15]. They were 
cultured in DMEM containing 10% FBS and 1 mg/ml G418. Primary cardiomyocytes 
isolated from neonatal rats and H9c2 cells derived from rat ventricular myocytes were 
also used. HEK293 (human embryonic kidney) cells, cultured in DMEM containing 
10% FBS, were used for transfections, since the transfection efficiency was better. 
 
cDNA Subtraction Assay  
In order to screen for genes that were more highly expressed in VHL-negative cells than 
in VHL-positive cells, a cDNA subtraction assay was performed using a SMARTTM 
PCR cDNA Synthesis Kit and a PCR-SelectTM cDNA Subtraction Kit (CLONTECH 
Laboratories Inc., Palo Alto, CA, USA) [17], as previously described [2]. The results of 
the subtraction assay were then evaluated by RT-PCR using nested primers targeting the 
sequenced genes. After searching the database using a segment of an interesting gene, 
the full-length sequences of interesting genes were obtained from GenBank; and those 
full-length genes were subcloned into pcDNA3.1 expression vector with a His tag 
sequence, or pIRES-EGFP (Clontech, Mountain View, CA, USA).  
 
Western Blot Analysis 
Whole cell lysates from VHL-positive or VHL-negative cells were fractionated by 
SDS-PAGE and transferred onto membranes (Millipore Corp., Bedford, MA, USA). 
The membranes were incubated with antibodies against GRP78, HIF-1D, VHL (BD 
Biosciences, San Jose, CA, USA) or α-tubulin. After reaction with secondary antibodies, 
the signals were detected using ECL Plus (Amersham, Buckinghamshire, UK).  
 
Transfection of HEK293 Cells  
The AI gene was transfected into HEK293 cells using EffecteneTM (QIAGEN, Valencia, 
CA, USA). In gene knockdown experiments, siFECTORTM (B-Bridge International, Inc., 
Sunnyvale, CA, USA) was used. In another experiment for transfection, wild-type (WT) 
or dominant negative (DN) HIF-1D vector, subcloned into pcDNA3.1 expression vector, 
was also used [2]. Forty eight hours after transfection, the cells were used for further 
studies.  
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Reporter Assay for Mitochondrial Transcription Factor A (TFAM) Transcriptional 
Activity 
The 5’-regulatory promoter region of rat TFAM (700 bp) was subcloned into a reporter 
vector (TOYO B-Net Co. Ltd., Tokyo, Japan) [18]. The reporter vector was 
co-transfected with or without the AI gene expression vector into HEK293 cells. Forty 
eight hours later, the cells were lysed and the luciferase activities were measured and 
corrected by the levels produced by the SeaPansy luciferase vector (TOYO B-Net Co. 
Ltd., Tokyo, Japan). 
 
RT-PCR 
Total RNA was isolated from VHL-negative and VHL-positive cells and 
reverse-transcribed to obtain first-strand cDNAs, which was amplified using specific 
primers for the AI gene, as follows: AI (sense), 5’GAATGCAGAAAAGCTTCATG3’; 
AI (antisense), 5’TAGCTAGCTCAGTAGAGTCTTTCCCC3’. PCR products were 
fractionated by electrophoresis. 
 
Assessment of Cell Number 
After performing MTT reduction assays, the cells were treated with a 0.05% 
trypsin-0.23 mM EDTA solution. And the cell number of the suspension was counted. 
 
MTT Activity Assay 
Measurements of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) 
reduction activity were performed in cells, which were transfected with or without the 
AI gene, containing comparable cell numbers, using an assay kit (Dojindo, Kumamoto, 
Japan). The mitochondrial function of cardiomyocytes was also evaluated using this 
assay system [19]. 
 
Caspase-3 Activity Assay  
Caspase-3 activity was measured using an assay kit (MBL, Tokyo, Japan) [20]. Briefly, 
cell lysates were mixed with a caspase-3 substrate and fluorometric measurements were 
performed. The caspase-3 activity in hypoxic cells was compared with that in normoxia. 
 
Flow Cytometry Analysis  
HEK293 cells were cotransfected with GFP and AI genes, or transfected with the GFP 
gene alone, and then analyzed by flow cytometry to examine whether the AI gene 
affected the cell cycle. After suspended cells were fixed in 70% ethanol, they were 
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treated with RNAase A (1 mg/mL) and mixed with propidium iodide (20 mg/mL); cells 
were then analyzed using a FACSCalibur System (Becton Dickinson, Boston, USA). 
The percentage of each cell cycle phase was compared. 
 
Immunocytochemistry of Transfected cells 
Localization of the AI protein was analyzed by immunocytochemistry. Transfected 
HEK293 cells were fixed and treated with 0.1% Triton X100. After blocking, cells were 
incubated with an anti-His monoclonal antibody (QIAGEN, Valencia, CA, USA), 
followed by incubation with an FITC-conjugated anti-mouse IgG antibody, and finally 
analyzed by fluorescence microscopy. 
 
Adenoviral Infection of the AI Gene into Rat Primary Cardiomyocytes 
The full-length human AI gene was subcloned into the pShuttle vector possessing CMV 
promoter according to the protocol. As a negative control, pShuttle vector containing 
LacZ was also prepared. After linearization, the plasmids were each co-transfected into 
Escherichia coli together with pAd, an adenoviral DNA plasmid (BD Adeno-X 
Expression System, BD Biosciences, San Jose, CA, USA). Recombinant adenoviral 
constructs were selected, digested with PacI and transfected into HEK293 cells to 
produce viral particles. Adenoviral infection was performed at a multiplicity of infection 
(MOI) of 100. Rat cardiomyocytes were transfected with the adenovirus for 72 hours 
and used for further experiments. 
 
Analysis of the Intracellular Calcium Response in AI-transfected Cells 
pIRES-EGFP expression vector containing the AI gene was transfected into HEK293 
cells. After 48 hours, these cells were loaded with a rhod-2 AM ester (5 PM; Molecular 
Probe, Eugene, OR, USA), and then stimulated with 100 PM ACh, which 
phosphorylates Akt through muscarinic receptors. The calcium responses in 
AI-expressing cells were evaluated using an imaging system (AQUACOSMOS, 
Hamamatsu Photonics, Hamamatsu, Japan) and analyzing software. 
 
Measurement of Oxygen Consumption by Cells 
At 48 hours after transfection, cells were lysed in a lysis buffer, and the mitochondrial 
fraction was obtained by sequential centrifugation. Pellets were resuspended in a 
suspension buffer, and mitochondrial respiration was initiated by the addition of 30 mM 
ADP, 1.2 M succinate and 0.5 M PBS. The mixture was applied to a Biological Oxygen 
Monitor (YSI Japan Ltd., Tokyo, Japan) and the respiratory control index (RCI) was 
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evaluated as the ratio of state 3 to state 4 respiration. 
 
siRNA for AI 
To silence the effect of AI gene expression in HEK293 cells, small interfering RNAs 
(siRNAs) were used. The best sequence of siRNA duplex was selected, and an siRNA 
duplex of 21-nucleotides was synthesized (TAKARA BIO INC., Otsu, Japan). The sense 
strand of the siRNA for the AI gene (AI siRNA) was 
GAACAAUGCCCUAUUAAGUTT. Nonspecific siRNA was also used as a negative 
control for comparison (CCGUUUACAACGAUAGAAUTT, unrelated siRNA). 
Transfection was carried out using siFECTOR (B-Bridge International, Inc., Sunnyvale, 
CA, USA) with 50 pmol/dish siRNA added to 1.5 Pl of siFECTOR according to the 
manufacturer’s protocol. 
 
Statistical Analysis 
The data are presented as means r S.E. Mean values were compared between the two 
groups using an unpaired Student’s t-test. Differences among data from the in vitro 
studies were assessed by ANOVA for multiple comparisons of results. Differences were 
considered significant at P<0.05.
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Results 
 
VHL-negative Cells Express More HIF-1D but Less GRP78 than VHL-positive Cells 
under Normoxia with a Decrease in Mitochondrial Function 
As shown in Figure 1, the HIF-1D protein level was higher in VHL-negative cells than 
VHL-positive cells. By contrast, the VHL protein level was decreased in the former 
cells, indicating that the HIF-1D protein expression level is increased in VHL-negative 
cells, even under normoxia. 
   As shown in Figure 2A, neither of the cell types showed any cell death, regardless 
of the VHL expression level, as evaluated by the absence of floating cells. Both cell 
types comparably reached 100% confluence. To investigate the other characteristic 
differences between them, the expression levels of GRP78, an ER stress marker, were 
examined. VHL-negative cells showed lower GRP78 expression levels than 
VHL-positive cells, indicating that the former cells are subjected to less ER stress 
(Figure 2B). Furthermore, MTT reduction activity was lower in VHL-negative cells 
(74.6r5.3%) than VHL-positive cells (100.0r3.7%; n=6, P<0.01), despite the 
comparable cell numbers (Figure 2C). This result indicates that the mitochondrial 
function in VHL-negative cells is relatively decreased, because MTT reduction activity 
depends on mitochondrial respiratory chain function. 
 
cDNA Subtraction to Identify Genes Responsible for the Lower Expression of GRP78 
VHL-negative cells, with a high HIF-1α level under normoxia, showed a decreased 
GRP78 expression in response to stress. Therefore, we hypothesized that VHL-negative 
cells show less stress than VHL-positive cells, and that some HIF-1D-regulated genes, 
which modulate the stress level, could be identified by screening via cDNA subtraction 
between two cell types. Thereafter, we obtained one gene, which had already been 
reported, with the GenBank accession number (BT008120) and tentatively named 
apoptosis inhibitor (AI) 5 gene. As depicted in Figure 3A, the AI mRNA level was 
increased in VHL-negative cells compared with VHL-positive cells. The AI mRNA 
expression levels were increased by hypoxia (1% oxygen) in both HEK293 and H9c2 
cells (Figure 3B), suggesting that AI expression is induced by hypoxia. Analysis of the 
tentative 5’-promoter region of the AI gene in the EMBL database revealed one 
hypoxia-responsive element (HRE), a DNA-binding site for HIF-1D, in that region 
(AY265937). This finding may support our results. 
 
HIF-1D increases AI mRNA levels and negatively affects GRP78 expression 
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To confirm that HIF-1D directly affects AI gene expression and, furthermore, GRP78 
expression, the effects of wild-type (WT) HIF-1D on the expression of AI gene were 
compared with those of dominant negative (DN) HIF-1D. AI mRNA expression was 
decreased by DN HIF-1D, compared with WT HIF-1D (69.3r0.8% vs. 175.3r11.8%, 
n=6, P<0.01) (Figure 3C). By contrast, DN HIF-1D adversely increased the GRP78 
expression level, compared with WT HIF-1D (190.9r2.7% vs. 114.4r2.7%, n=3, 
P<0.05). The difference in the effects of WT and DN HIF-1D on AI mRNA or GRP78 
expression was more evident than between those of control and WT HIF-1D. These 
findings suggest that HIF-1D positively regulates AI gene expression and also affects 
GRP78 expression (Figure 3D). 
 
Nuclear AI is Involved in the Reduced GRP78 Expression 
To investigate the function of the AI gene, the GRP78 response was assessed in the 
presence of tunicamycin, an ER stressor. In the presence of tunicamycin, the GRP78 
expression levels were increased in non-transfected control cells, GFP-transfected cells 
and empty expression vector-transfected cells. However, compared with these cells 
showing increased GRP78 levels, AI-transfected cells exhibited remarkably decreased 
GRP78 expression (Figure 3E). Using an anti-His-tag antibody, AI was detected in the 
nucleus (Figure 3F). However, the proportions of cells at each cell cycle phase were 
comparable between the AI-transfected cells and non-transfected cells (55.0% and 
58.6% in G1 phase, 28.8% and 25.9% in S phase, and 16.3% and 15.4% in G2M, 
respectively) (data not shown), suggesting that AI does not affect the cell cycle. 
 
AI Modifies Mitochondrial Function through Downregulation of TFAM 
Despite the presence of comparable cell numbers, as shown in Figure 4A, MTT 
reduction activity was decreased in AI-transfected cells (to 43.0r2.5%) compared with 
GFP-transfected cells (101r3.1%; n=8, P<0.01), indicating that AI inhibits 
mitochondrial function, as occurs in VHL-negative cells (Figure 2C), since the MTT 
reduction activity reflects complex II activity in mitochondria. To investigate the 
mechanism by which mitochondrial function is affected by AI, reporter assays were 
carried out using a 5’-flanking regulatory region of the human mitochondrial 
transcriptional factor A (TFAM) gene. TFAM is an essential transcription factor 
encoded by nuclear DNA, which regulates the transcription of mitochondrial DNA. The 
transcriptional activity of the reporter vector in the presence of the TFAM flanking 
region (TFAM) was 378r or 739r55 RLU compared with the basic vector or SV 
promoter vector alone, respectively (Figure 4B). By contrast, AI decreased the 
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luciferase activity (TFAM+AI) to 267r10 or 397r019 RLU, respectively, suggesting 
that AI interferes with TFAM transcriptional activation (n=8, P<0.01 vs. TFAM), and 
inhibits mitochondrial function.    
    
AI Attenuates Calcium Response Following Stimulation 
The facts that AI reduces GRP78 expression, TFAM transcription and mitochondrial 
function prompted us to speculate that AI suppresses various cellular responses, 
including the calcium response. Therefore, we investigated the effect of AI on the 
calcium response. It had already been confirmed that ACh phosphorylates Akt and 
modulates intracellular calcium levels in HEK293 cells (data not shown). Intracellular 
calcium levels were elevated in GFP-transfected cells stimulated by ACh (100 PM) 
(upper panel in Figure 4C). This elevation was comparable with the calcium responses 
seen in non-transfected HEK293 cells (data not shown). However, as shown in the 
lower panel, the calcium responses in AI-transfected cells were remarkably attenuated, 
suggesting that AI affects the calcium response (n=20, P<0.05 vs. GFP). 
 
AI Gene Decreases Oxygen Consumption in Cardiomyocytes 
Oxygen consumption was evaluated using the respiratory control index (RCI) (Figure 
4D). In AI-transfected HEK293 cells, the RCI was decreased (to 1.3r0.1), compared 
with that in GFP-transfected cells (2.0r0.1; n=5, P<0.05). Likewise, adenoviral 
infection of AI into rat primary cardiomyocytes caused a decrease in RCI (to 1.5r0.1), 
compared with that in LacZ-transfected cells (2.0r0.1; n=5, p<0.05). These results 
indicate that AI decreases oxygen consumption and leads to a decrease in energy 
metabolism. 
 
AI Decreases the Hypoxia-induced Elevation of Caspase-3. 
In the absence of the AI gene, hypoxia (1% oxygen) increased caspase-3 activity (to 
128.0r3.0%). By contrast, hypoxia did not increase caspase-3 activity in AI-transfected 
HEK293 cells (89.5r1.4%; n=5, P<0.01) (Figure 4E), suggesting that AI inhibits the 
apoptosis induced by hypoxia. AI was identified to suppress mitochondrial function, 
therefore, it could be speculated that AI is induced by an adaptation to hypoxia.  
Inadequate induction level of AI can not efficiently prevent hypoxia-induced apoptosis; 
however, greater levels of AI induction could lead to cellular protection. 
 
Knockdown of AI using siRNA increases MTT reaction activity even with comparable 
cell numbers 
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To clarify the significance of AI, AI siRNA or unrelated siRNA was transfected into 
HEK293 cells. Initially, the efficiency of siRNA to knockdown AI expression was 
verified (Figure 4F). AI expression, detected in the nucleus, was greatly suppressed by 
the AI siRNA. Compared with the MTT reduction activities in non-transfected cells 
(control, 100r6.3%) or unrelated siRNA-transfected cells (unrelated siRNA, 
98.7r5.1%), the MTT activities of AI siRNA-transfected cells were significantly higher, 
even with adjustment for cell numbers (AI siRNA, 150.0r6.0%; n=10, p<0.01 vs. 
control and unrelated siRNA). Taken together with the results from the AI gene 
introduction study, this finding suggests that AI plays a pivotal role in regulating 
mitochondrial function. 
 
Acute myocardial ischemia increases AI mRNA 
Ischemia of the heart, induced by left coronary ligation for 3 hours, resulted in an 
increase in AI mRNA expression (Figure 4G), consistent with an earlier finding in H9c2 
cells, which showed increased AI mRNA expression in response to hypoxic stress 
(Figure 3B). This in vivo result suggests that AI induction by ischemia may be due to 
adaptation of the heart. 
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Discussion 
 
The present study revealed that AI exerts anti-stress effects by suppressing 
mitochondrial function, thereby reducing oxygen consumption and inhibiting 
hypoxia-induced apoptosis. These effects are achieved via transcriptional repression of 
mitochondrial transcription factor A (TFAM). This study, therefore, shows that AI plays 
a crucial role in suppressing mitochondria during hypoxia, leading to the salvaging of 
cells. 
These results suggest a potential advantage of a nonhypoxic induction pathway of 
HIF-1D in a clinical setting. We have recently revealed that ACh exerts a 
cardioprotective action through the PI3K/Akt/HIF-1D/VEGF signaling pathway, and 
that it inhibits the collapse of mitochondria membrane potential [2]. Therefore, the 
possibility is raised that the beneficial effects of ACh might be attributed to modulation 
of cardiac mitochondria. However, there are few adequate studies regarding the linkage 
between ACh and mitochondrial function in cardiomyocytes. Therefore, we have 
studied which factors might link HIF-1D to mitochondrial function and then found a cue 
from AI gene. 
TFAM plays key roles in mitochondrial DNA maintenance and mitochondrial 
biogenesis, since complete inactivation of TFAM causes cardiomyopathy [21, 22]. 
Therefore, TFAM is definitely essential for the homeostasis of energy metabolism in 
cells. In the present study, however, AI partially decreased the TFAM promoter activity 
and suppressed oxygen consumption. It was therefore revealed that the principal 
function of AI is to decrease energy metabolism, and that AI plays a role in protecting 
cells against hypoxia. Since AI is screened from cells with higher expression levels of 
HIF-1D, these results are compatible, and suggest that AI is one of the targets of HIF-1D 
responsible for cell protection against hypoxic conditions. 
The AI gene has already been reported under GenBank accession number BT008120 
as an apoptosis inhibitor (AI). One study reported another related gene, designated the 
AAC-11 gene, which shows partial amino acid sequence identity to the AI gene [23]. 
AAC-11 gene-transfected cells are resistant to apoptosis [23, 24]; just as AI-transfected 
cells are resistant to hypoxia-induced apoptosis. It was demonstrated that increased 
AAC-11 mRNA expression is correlated with a poor prognosis for patient with 
non-small cell carcinoma [24] and cervical carcinoma [25]. Unlike AAC-11, however, 
the functions of BT008120, AI, have remained unknown. Therefore, our present study 
reveals a novel function of AI in terms of the modification of mitochondrial function. 
Based on the facts that VHL-negative cells with higher HIF-1D expression levels 
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showed lower MTT reduction activity than VHL-positive cells, it is suggested that 
VHL-negative cells utilize less mitochondrial function, because the MTT reduction 
activity represented by complex II activity is reduced. It is further suggested that 
increased HIF-1D expression is adversely related to decreased mitochondrial function. 
Compatible with this, the levels of AI mRNA were increased by hypoxia and ischemia, 
and AI gene expression was increased by HIF-1D.  
Cardiomyocytes, which are rich in mitochondria, efficiently produce adequate ATP 
through the mitochondrial respiratory chains, but simultaneously produce endogenous 
reactive oxygen species (ROS). It was also established that mitochondria play crucial 
roles in executing apoptosis [26, 27]; therefore, E-blockers are widely used in patients 
with heart failure to achieve a better outcome [28-32] through the reduction of cardiac 
work, as AI suppresses mitochondrial energy metabolism via a decrease in oxygen 
consumption. Consequently, it is suggested that AI suppresses energy metabolism, 
resulting in the circumvention of apoptotic stresses. 
In agreement with this, AI also decreased the level of GRP78 expression, suggesting 
that AI reduces cellular stress, decreases caspase-3 activity induced by hypoxia and 
attenuates the calcium response. The UPR is activated by stresses and up-regulates 
protective ER-related proteins, including GRP78. Recent studies have revealed that 
hypoxia causes ER stress in cardiomyocytes with elevated GRP78 levels [33, 34]. 
According to an elegant study by Terai et al. [34], activation of a cell-protective kinase 
(AMPK) inhibits apoptosis without GRP78 induction. A crucial point in our present 
study is that AI also exerts cell-protective effects upstream of GRP78, and primarily 
makes cells more resistant to stress by suppressing energy metabolism. It is therefore 
speculated that a reduction of energy metabolism by AI is associated with the 
diminution of oxidative stresses, lower proliferation and decreased protein synthesis, 
and that these mechanisms could decrease ER stress [35]. Consequently, this study 
reveals a missing link between AI, HIF-1D, mitochondria and stresses.   
Although AI decreased MTT reduction activity in normoxia, leading to decreased 
mitochondrial function, MTT reduction activity was surprisingly up-regulated by 
knockdown of AI, indicating that mitochondrial function is adversely activated by AI 
siRNA. Taken together, these findings suggest that AI plays a critical role in negatively 
modulating mitochondrial function.  
In conclusion, the present study has identified the AI gene, which is regulated by 
HIF-1D, as a candidate gene that may be involved in the inhibition of energy 
metabolism and apoptosis under hypoxic conditions. These effects of AI could 
contribute to cellular protection. 
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Figure legends 
 
Figure 1 
The protein level of HIF-1D is greatly increased in VHL-negative cells compared with 
VHL-positive cells, even under normoxia.  
VHL-positive cells express the VHL protein, whereas VHL-negative cells do not. By 
contrast, VHL-negative cells express more HIF-1D protein, even under normoxia, than 
VHL-positive cells (n=4). Representative data are shown. 
 
Figure 2 
VHL-negative cells show lower expression of GRP78 protein with reduced 
mitochondrial function. 
A, both VHL-positive cells and VHL-negative cells proliferate well without cell death, 
as evaluated by the absence of floating cells. When the numbers of both cell types are 
comparable, evaluated by counting cells, no morphological differences are observed. B, 
VHL-negative cells show lower GRP78 expression than VHL-positive cells despite the 
comparable cell numbers, as indicated by the D-tubulin expression levels (n=4). C, 
compatible with decreased GRP78 expression, VHL-negative cells also show 
significantly lower MTT reduction activity (74.6r5.3%) than VHL-positive cells 
(100.0r3.7%; n=6, P<0.01), despite the comparable cell numbers. 
 
Figure 3 
The expression of the AI gene, which is localized in the nucleus, is increased under 
hypoxia and involved in the reduction of GRP78 expression through HIF-1D.  
A, even under normoxia, AI mRNA gene expression is increased in VHL-negative cells 
compared with VHL-positive cells, as evaluated by RT-PCR (n=5). B, AI mRNA 
expression is increased by hypoxia (1% oxygen) in HEK293 cells as well as H9c2 cells 
(n=5). C, The wild-type form (WT) of HIF-1D slightly increases AI gene expression; 
however, the dominant negative form (DN) adversely decreases AI gene expression, as 
evaluated by RT-PCR (n=6, P<0.01). D, Compared with WT HIF-1D, GRP78 
expression was up-regulated by DN HIF-1D (n=3, P<0.05). E, AI suppresses the 
increase in GRP78 expression in HEK293 cells induced by 5 Pg/ml tunicamycin; 
adversely non-transfected control cells, GFP-transfected cells and empty 
vector-transfected cells all responded to tunicamycin with elevated GRP78 expression 
(n=5). F, labeling with an anti-His tag antibody reveals that the His-tagged AI protein is 
localized in the nucleus, and not in the cytoplasm.  
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Figure 4 
The AI gene regulates mitochondrial function by modifying the transcriptional 
activation of mitochondrial transcription factor A (TFAM), leading to a decrease in 
oxygen consumption, and inhibition of hypoxia-induced apoptosis. 
 
A, the MTT reduction activity in AI-transfected cells is decreased (to 43.0r2.5%) 
compared with that in GFP-transfected cells (101.3r3.1%; n=8, P<0.01), despite the 
comparable cell numbers. B, reporter assays reveal that AI suppresses the transcriptional 
activity of TFAM in two different luciferase vectors, compared with TFAM alone 
(378r15 to 267r10 RLU in basic vector, 739r55 to 397r19 RLU in SV promoter vector, 
n=8 in each reporter assay experiment, P<0.01 vs. TFAM). C, The calcium response is 
reduced by AI. Intracellular calcium accumulation in HEK293 cells is increased in 
response to exogenous application of 100 PM ACh. However, in AI-transfected 
HEK293 cells the response is suppressed (n=20, P<0.05 vs. GFP). Four representative 
calcium response traces are shown. D, Transient transfection of the AI gene into 
HEK293 cells decreases their oxygen consumption compared with that in 
GFP-transfected cells, as evaluated by the RCI. Furthermore, rat primary 
cardiomyocytes infected with AI adenovirus also show reduced oxygen consumption 
(n=5, P<0.05 vs. GFP or LacZ). E, caspase-3 activity in HEK293 cells is increased by 
hypoxia, and AI suppresses this elevation of caspase-3 activity (n=5, P<0.01 vs. control). 
F, knockdown of the AI gene significantly increases the MTT reduction activity in 
HEK293 cells under ordinary culture conditions, compared with that of non-transfected 
control cells or unrelated siRNA-transfected cells (n=10, p<0.01 vs. control or unrelated 
siRNA). G, Myocardial ischemia for 3 hours increased the level of AI mRNA expression 
in the heart, compared with non-ischemic heart, as evaluated by RT-PCR (n=4). 
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